Protocols - Hemorio
Protocols - Hemorio
Protocols - Hemorio
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
SUMMARY:<br />
PART I - CLINICAL PROTOCOLS ON HEMATOLOGICAL DISEASES .................................................... 7<br />
SICKLE CELL DISEASE .............................................................................................................................................................................................. 8<br />
MAJOR AND INTERMIDIATE THALASSEMIA ......................................................................................................................................................... 40<br />
HEREDIRATY SPHEROCYTOSIS ............................................................................................................................................................................ 42<br />
G6PD DEFICIENCY ................................................................................................................................................................................................... 44<br />
APLASTIC ANEMIA ................................................................................................................................................................................................... 46<br />
SELFIMMUNE HEMOLYTIC ANEMIA ....................................................................................................................................................................... 48<br />
IMMUNE THROMBOCYTOPENIC PURPURA ........................................................................................................................................................ 51<br />
IMMUNE THROMBOCYTOPENIC PURPURA ........................................................................................................................................................ 52<br />
THROMBOTIC THROMBOCYTOPENIC PURPURA ................................................................................................................................................ 54<br />
HEMORRHAGIC SYNDROME .................................................................................................................................................................................. 56<br />
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA ................................................................................................................................................. 81<br />
GAUCHER DISEASE ................................................................................................................................................................................................. 83<br />
MYELODISPLASIC SYNDROME .............................................................................................................................................................................. 86<br />
ACUTE MYELOID LEUKEMIA ................................................................................................................................................................................... 90<br />
LMA IN CHILDREN AND TEENAGERS .................................................................................................................................................................... 98<br />
CHRONIC MYELOID LEUKEMIA ............................................................................................................................................................................ 103<br />
POLYCYTHEMIA VERA .......................................................................................................................................................................................... 106<br />
ESSENTIAL THROMBOCYTHEMIA ....................................................................................................................................................................... 107<br />
PRIMARY MYELOFIBROSIS .................................................................................................................................................................................. 109<br />
ACUTE LYMPHOID LEUKEMIA .............................................................................................................................................................................. 110<br />
NON-B ACUTE LYMPHOID LEUKEMIA AND LYMPHOBLAST LNH (CHILD) ...................................................................................................... 115<br />
CHRONIC LYMPHOCYTIC LEUKEMIA .................................................................................................................................................................. 120<br />
TRICHOLEUKEMIA ................................................................................................................................................................................................. 124<br />
HODGKIN’S LYMPHOMA ........................................................................................................................................................................................ 125<br />
NON-HODGKIN’S LYMPHOMA .............................................................................................................................................................................. 127<br />
PROGNOSIS – FLIPI CRITERION .......................................................................................................................................................................... 128<br />
LEUKEMIA / T-CELLS LYMPHOMA OF THE ADULT ............................................................................................................................................ 140<br />
FUNGOID MYCOSIS AND SÉZARY SYNDROME ................................................................................................................................................. 141<br />
MULTIPLE MYELOMA ............................................................................................................................................................................................. 144<br />
WALDENSTRON MACROGLOBULINEMIA............................................................................................................................................................ 148<br />
BONE MARROW TRANSPLANT ............................................................................................................................................................................ 149<br />
PART II - TRANSFUSIONAL PROTOCOLS AT THE HEMATOLOGICAL DISEASES .......................... 158<br />
MAIN BLOOD COMPONENTS ................................................................................................................................................................................ 159<br />
TRANSFUSION OF RED BLOOD CELLS, PLATELETS, FROZEN FRESH PLASMA AND GENERAL INDICATIONS ...................................... 162<br />
GENERAL INDICATIONS ........................................................................................................................................................................................ 162<br />
TRANSFUSIONAL INDICATIONS AT THE HEMATOLOGICAL DISEASES ......................................................................................................... 169<br />
SPECIAL PROCEDURES ........................................................................................................................................................................................ 177<br />
TRANSFUSIONAL REACTIONS ............................................................................................................................................................................. 179<br />
HEMOVIGILANCE AND TRANSFUSIONAL COMMITTEE .................................................................................................................................... 183<br />
PRACTICAL ASPECTS OF THE TRANSFUSION .................................................................................................................................................. 183<br />
ATTACHMENTS....................................................................................................................................... 185<br />
ATTACHMENT I – HEMATOLOGICAL CLINICAL SCREENING ........................................................................................................................... 186<br />
ATTACHMENT II – HEMORIO’S DISCHARGE CRITERIA .................................................................................................................................... 193<br />
ATTACHMENT III – HEMATOLOGY SPECIAL TECHNIQUES .............................................................................................................................. 194<br />
ATTACHMENT IV – PAIN APPROACH ROUTINE ................................................................................................................................................. 198<br />
ATTACHMENT V – CHEMOTHERAPY SUBJECTS CARE ................................................................................................................................... 212<br />
ATTACHMENT VI – RENAL AND HEPATIC ADJUSTMENT OF THE MOST USED DRUGS IN HEMATOLOGY ............................................... 213<br />
ATTACHMENT VII – IRON CHELATION ................................................................................................................................................................ 214<br />
ATTACHMENT VIII – SEDATION IN CHILDREN ................................................................................................................................................... 218<br />
ATTACHMENT IX – TRANSFUSION OF PLATELETS CONCENTRATE .............................................................................................................. 219<br />
AT THE HEMORRHAGIC DENGUE ....................................................................................................................................................................... 219
Change language